What is the catalog number for Kv1.4/KCNA4 Rabbit Polyclonal Antibody?

The catalog number for Kv1.4/KCNA4 Rabbit Polyclonal Antibody is orb334539.

What sizes are available for Kv1.4/KCNA4 Rabbit Polyclonal Antibody?

Kv1.4/KCNA4 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Kv1.4/KCNA4 Rabbit Polyclonal Antibody in stock?

Kv1.4/KCNA4 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Kv1.4/KCNA4 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Potassium voltage-gated channel subfamily A member 4; HPCN2; Voltage-gated K (+) channel HuKII; Voltage-gated potassium channel HBK4; Voltage-gated potassium channel HK1; Voltage-gated potassium channel subunit Kv1.4; KCNA4; KCNA4L

UniProt

P22459

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins.

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human Kv1.4, different from the related mouse sequence by two amino acids, and from the related rat sequence by one amino acid.

Target

Potassium voltage-gated channel subfamily A member 4

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Epigenetics & Chromatin

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

73 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.